North America Frac Sand, Inc. dba Voycare (OTC: NAFS) (NAFS or Voycare), a California-based telemedicine and medical tourism service provider is introducing today Hera, a digital health platform exclusively for women in China. The secure online platform will help women connect with vetted health providers in China and internationally via online audio/video calls with simultaneous Chinese interpretation, all from the comfort of their own homes. The online consultations will allow women to engage and vet health providers before committing to treatment and traveling to the destination of the provider. The platform will also offer second opinion services and will coordinate with Voycare for all medical travel needs.
Voycare is excited to be introducing a more inclusive and supportive way for women to receive health care in China, said Voycare Head of Product, Ellen Wu. Hera is filling a void for many Chinese women who are not in control of their decision-making when it comes medical care. By leveraging virtual care, we are creating a more transparent and user-centric approach in identifying, vetting and selecting the right health care provider in a destination of choice.
Hera or known by its Chinese name Hela Jian Kang, will provide access to top doctors and clinics both domestic and overseas. The areas of care will focus on pre and post pregnancy medical specialties. Currently 40 million women in China are experiencing infertility problems. Add to that another 30 percent of new mothers are diagnosed with postpartum depression, and up to 85 percent of mothers may experience depressive feelings after giving birth. Provider countries will include the China, U.S., Ukraine, Russia, South Korea, Thailand, Singapore, Malaysia and Australia.
We're living in unprecedented times right now, as evident by the current Coronavirus pandemic, said Xuemei Li Voycare COO. We've never seen such high demand for telehealth services until now because of the outbreak. China in particular is ripe for telehealth and women's health is no exception. Women want access to the best medical minds in women's health, as well as transparency about treatments and pricing to help them make more informed decisions in choosing the right care in China or abroad.
China had already been experiencing rapid growth in telemedicine, with a projected market size of 700 billion RMB ($US100 billion) by the end of 2020 according to Phoenix News Media, but with the latest COVID-19 Coronavirus outbreak, the demand for telehealth services has never been greater than now.
Originally slated for a launch later in the year, Voycare is pushing go live with the Hera platform in the spring in order to better facilitate users who continue to seek medical treatment during the outbreaks travel restrictions currently affecting domestic and international travel in China.
For more information about Voycare, please visit, www.voycare.com or follow us on Twitter @nafsvoycare.
North America Frac Sand, Inc. (OTC: NAFS) dba Voycare (www.voycare.com) is a California based medical tourism and telemedicine service provider helping overseas patients gain access to quality health care primarily in the fields of oncology, in vitro fertilization, cosmetic surgery and wellness. Voycare's executive team has over 20 years of cross border tourism experience, specifically servicing Chinese outbound travelers to North and South America.
Safe Harbor Statement
This news release contains certain forward-looking information. All information, other than information regarding historic fact that addresses activities, events or developments that the Company believes, expects or anticipates will or may occur in the future is forward-looking information. The forward-looking information contained in this news release reflects the current expectations, assumptions and/or beliefs of the Company based on information currently available to the Company. The forward-looking information contained in this news release is subject to a number of risks and uncertainties that may cause actual results or events to differ materially from current expectations. Any forward-looking information speaks only as of the date on which it is made and, except as may be required by applicable law, the Company disclaims any obligation to update or modify such forward-looking information, either because of new information, future events or for any other reason. Although the Company believes that the assumptions inherent in the forward-looking information are reasonable, forward-looking information is not a guarantee of future performance and accordingly undue reliance should not be put on such information due to the inherent uncertainty therein.
China Telemedicine market reference: